Pure Global AI
Ravimiamet market access

Estonia medical device registration resources

Research Ravimiamet registration records, classification, regulations, timelines, fees, and market updates — the stable entrance to every Estonia medical device resource.

5 free resources23/25 topics with records3 regulations trackedSep 2026 fees reviewed
Run the classification agent

Everything we track for Estonia

Browse by resource instead →

AI medical device classifier

Describe your device and get a preliminary Ravimiamet risk class with an explanation and source links.

Additional certification and licence checker

Check whether product features may trigger separate radio, electrical, metrology, radiation, import, or other Estonia requirements.

Government registration fees

Review current Ravimiamet application, review, and renewal fees.

Registration timeline

Compare official and realistic approval times by device class and pathway.

Medical device regulations

Browse Estonia's official medical-device instruments — the Medical Devices Act and the applicable EU MDR and transitional-amendment texts — with citeable Estonian and English passages.

Structured regulatory requirements

Explore all 38 source-linked facts →

23 of 25 research dimensions currently covered · 17 official sources · latest verification 2026-09-16

Market entry

D01

Authority & regime

Verified
Competent authority for medical devices
Ravimiamet (State Agency of Medicines) performs the tasks and issues the administrative acts of the competent authority, and of the authority responsible for notified bodies, laid down in t…
Supervision split between Ravimiamet and Terviseamet
Ravimiamet carries out state and administrative supervision over compliance with the Medical Devices Act, the legislation established under it and Regulations (EU) 2017/745 and 2017/746; su…
2 source-linked facts
Checked 2026-09-16
Open details →
D02

Legal basis & guidance

Verified
National act governing medical devices
The Estonian national act for medical devices is the Medical Devices Act (Meditsiiniseadme seadus, MSS), passed 13 October 2004 and published RT I 2004, 75, 520, in force since 1 December 2…
1 source-linked fact
Checked 2026-09-16
Open details →
D03

Device definition & scope

Verified
Authority may qualify a product as a medical device
Ravimiamet has the power to determine that a product is a medical device where the product meets the requirements set out in Regulation (EU) 2017/745 or Regulation (EU) 2017/746 — that is,…
1 source-linked fact
Checked 2026-09-16
Open details →
D04

Classification rules

Verified
EU MDR classes I, Is, Im, Ir, IIa, IIb and III
Class I, Class Is, Class Im, Class Ir, Class IIa, Class IIb, Class III
1 maintained scheme · 1 related fact
Checked 2026-09-16
Open details →
D05

Registration pathways

Verified
Custom-made device notification
Any undertaking that places a custom made device on the market must notify Ravimiamet of its intention at least ten days before making that device available on the market.
In-house manufactured devices listing
A health care provider, or a research and development institution, university or evaluated professional higher education institution that manufactures devices in house under MDR Article 5(5…
2 source-linked facts
Checked 2026-09-16
Open details →
D06

Reliance & recognition

Verified
CE marking under MDR/IVDR is the domestic route
statement: For Estonia the CE marking route is not a foreign approval but the domestic route: Regulations (EU) 2017/745 and (EU) 2017/746 apply directly in Estonia and the Estonian Medical…
US FDA clearance: no recognition route into Estonia
statement: A US FDA 510(k), De Novo or PMA clearance gives no market access route in Estonia. Estonia applies Regulation (EU) 2017/745 directly and a device may be placed on the Estonian ma…
2 source-linked facts
Checked 2026-09-16
Open details →
D07

Economic-operator roles

Verified
Authorised representative required for non-EU manufacturers
Where the manufacturer of a device is not established in an EU Member State, the device may be placed on the Union market — including the Estonian market — only if the manufacturer designat…
National duty framework for operators
For the duties of the manufacturer, its authorised representative, the importer and the distributor, the Medical Devices Act applies the requirements of the Product Conformity Act (toote nõ…
2 source-linked facts
Checked 2026-09-16
Open details →
D08

Establishment, import & distribution

Verified
Notification of first distribution in Estonia
Every undertaking that distributes on the Estonian market a system or procedure pack within the meaning of MDR Article 22, a class IIa, IIb or III medical device classified under Regulation…
Estonian medical devices and aids database (MSA)
Manufacturers or their authorised representatives, importers, distributors, professional users and lay users of medical devices, sellers and lessors of aids, and Tervisekassa submit data to…
2 source-linked facts
Checked 2026-09-16
Open details →
D09

Dossier requirements

Verified
What the Estonian Medical Devices Act adds to the dossier: retention of the documents available to Ravimiamet for the MDR/IVDR periods
The national addition to the dossier regime is a retention and availability duty. Under § 25 of the Medical Devices Act the manufacturer or its authorised representative must keep device re…
The device dossier in Estonia is the technical documentation of MDR/IVDR, applied directly
Estonia is a Member State of the European Union and applies Regulation (EU) 2017/745 and Regulation (EU) 2017/746 directly, so the device dossier is the technical documentation those Regula…
2 source-linked facts
Checked 2026-09-16
Open details →
D10

Official forms & portals

Verified
Free sale certificate: the statutory rule for the application and the certificate
The free sale certificate is a statutory service under § 32² of the Medical Devices Act. Ravimiamet issues it, on application, to a manufacturer or authorised representative registered in E…
1 source-linked fact
Checked 2026-09-16
Open details →

Submission & evidence

D11

Label, IFU & language

Verified
Language of the declaration of conformity and notified body certificates
The EU declaration of conformity of a device distributed in Estonia must be drawn up in Estonian or English, or translated into Estonian or English; a notified body registered in Estonia is…
Language of device information supplied with the device
Information accompanying a device placed on the market, made available, distributed or put into service in Estonia must be presented: in Estonian, in an appropriate manner, where the device…
2 source-linked facts
Checked 2026-09-16
Open details →
D12

QMS, audit & inspection

Verified
Ravimiamet's state supervision over devices and the inspection measures it may use
State and administrative supervision over compliance with the requirements laid down in the Medical Devices Act, in legislation adopted under it, and in Regulations (EU) 2017/745 and (EU) 2…
What the Estonian act adds to the Union QMS route: notified-body oversight and Ravimiamet's competent-authority role
The Estonian act adds the national institutional layer to the Union conformity assessment route. Under § 14(2) of the Medical Devices Act the notified body, its activity, the grant of its o…
3 source-linked facts
Checked 2026-09-16
Open details →
D13

Standards, testing & ancillary approvals

Unresolved
Low Voltage Directive exclusion for medical electrical equipment — electrical safety carried inside MDR conformity assessment
Electrical safety
EMC Directive disapplied where MDR fixes the same essential requirements
EMC
Radio-equipment essential requirements, conformity assessment and type registration (määrus nr 46)
Wireless / radio
6 maintained overlays · 1 related fact
Checked 2026-09-16
Open details →
D14

Fees

Verified
Notification of the first distribution of a device on the Estonian market (MSS § 26(4)) and submission of data to the medical devices and aids database (MSS § 29)
EUR 0
Review of an application to conduct a clinical investigation of a medical device, or a performance study of an in vitro diagnostic medical device
EUR 210.00
8 maintained fee lines · 1 related fact
Checked 2026-09-16
Open details →
D15

Review clocks

Unresolved
Class I · Self-declaration (no notified body)
0 days
Notification to Ravimiamet of the first distribution of a device on the Estonian market · National notification under MSS § 26(4)
10 days
Ravimiamet registration of a reported serious incident and acknowledgement to the reporter · National acknowledgement clock under MSS § 27(1)
10 working days
4 maintained pathways · 1 related fact
Checked 2026-09-16
Open details →
D16

Approval validity & renewal

Verified
Free sale certificate for export
On application, Ravimiamet issues a free sale certificate to a manufacturer or authorised representative registered in Estonia for the export of a medical device. The certificate attests th…
Transitional validity of MDD/AIMDD certificates
Devices holding a valid Directive 90/385/EEC or 93/42/EEC certificate may continue to be placed on the market until 31 December 2027 for class III devices and class IIb implantable devices…
2 source-linked facts
Checked 2026-09-16
Open details →

Lifecycle & post-market

D17

Change control

Verified
No significant changes condition for transitional devices
A device may rely on the extended transitional periods of Regulation (EU) 2023/607 only if there are no significant changes in its design and intended purpose; a significant change in desig…
Notification of significant changes to custom-made devices
The conditions and procedure for notifying the placing on the market of a custom made device, a significant change made to a custom made device, and the first distribution of a device in Es…
2 source-linked facts
Checked 2026-09-16
Open details →
D18

UDI, listing & traceability

Verified
UDI system and device registration
The Unique Device Identification system described in Part C of Annex VI to Regulation (EU) 2017/745 allows identification and facilitates traceability of devices, other than custom made and…
1 source-linked fact
Checked 2026-09-16
Open details →
D19

Clinical investigation & performance

Verified
Estonia's national addition: Ravimiamet's authorisation for a sponsor not established in the EU to designate a contact person
Where a study is planned to be conducted only in Estonia, or only in Estonia and in a country that is not a European Union or European Economic Area member state, and the sponsor is not reg…
Sponsor notification of low-intervention studies
A sponsor must notify Ravimiamet at least ten days before starting a study where the sponsor plans to conduct a clinical investigation referred to in Article 74 of Regulation (EU) 2017/745…
2 source-linked facts
Checked 2026-09-16
Open details →
D20

Special access & derogation

Verified
National derogation from conformity assessment
By way of derogation from the conformity assessment procedures, a competent authority may authorise, on a duly justified request, the placing on the market or putting into service within it…
1 source-linked fact
Checked 2026-09-16
Open details →
D21

Manufacturer PMS

Verified
Manufacturer post-market surveillance system
For each device, manufacturers must plan, establish, document, implement, maintain and update a post market surveillance system in a manner proportionate to the risk class and appropriate t…
1 source-linked fact
Checked 2026-09-16
Open details →
D22

Vigilance & incident reporting

Verified
Manufacturer duty to report serious incidents and field safety corrective actions
Manufacturers of devices made available on the Union market, other than investigational devices, must report to the relevant competent authorities — for Estonia, Ravimiamet — every serious…
National incident registration and field safety notice language
Ravimiamet registers the data of a serious incident reported to it and notifies the reporter of this within ten working days of submission of the data. A field safety notice concerning a de…
2 source-linked facts
Checked 2026-09-16
Open details →
D23

Recall, FSCA & market surveillance

Verified
Supervisory measures available to Ravimiamet
For the state supervision provided for in the Medical Devices Act, the supervising authority may apply the special state supervision measures of §§ 30, 31, 32, 49 and 50 of the Law Enforcem…
1 source-linked fact
Checked 2026-09-16
Open details →
D24

Advertising, claims & promotion

Verified
Medical device advertising in Estonia is governed by the general Advertising Act, and Ravimiamet supervises and prosecutes it
Estonia has no device specific advertising statute; device advertising is governed by the general Advertising Act (Reklaamiseadus), and the Act expressly names medical devices in the bodies…
1 source-linked fact
Checked 2026-09-16
Open details →
D25

Submission communications & appeal

Verified
Challenging a Ravimiamet act or measure: the general administrative-law remedy, since the Act's own challenge provision is repealed
There is no device specific appeal route in Estonian medical device law. The Medical Devices Act's own challenge provision, § 37 'Ettekirjutuse ja toimingu vaidlustamine' (challenge of a pr…
1 source-linked fact
Checked 2026-09-16
Open details →

Government fees

Full fee schedule (8 lines) →

Ravimiamet registration fees in EUR · reviewed 2026-09-16

Fee lineAmountProvenance
Notification of the first distribution of a device on the Estonian market (MSS § 26(4)) and submission of data to the medical devices and aids database (MSS § 29)EUR 0Verified
Review of an application to conduct a clinical investigation of a medical device, or a performance study of an in vitro diagnostic medical deviceEUR 210.00Verified
Free-sale certificate (vabamüügi sertifikaat) issued within 45 days of applicationEUR 154.00Verified
Duplicate of a free-sale certificateEUR 32.00Verified
4 more fee lines on the full schedule · 8 of 8 rows source-verified

Registration timeline

Full registration timeline →

Ravimiamet (Ravimiamet) review clocks and planning ranges · 4-class (I, IIa, IIb, III) — EU MDR classification

Class / pathwayReview clockPlanning totalProvenance
Class I(Self-declaration (no notified body))0 days6-9 monthsVerified
Notification to Ravimiamet of the first distribution of a device on the Estonian market(National notification under MSS § 26(4))10 days10-20 daysVerified
Ravimiamet registration of a reported serious incident and acknowledgement to the reporter(National acknowledgement clock under MSS § 27(1))10 working days10-25 working daysVerified
Ravimiamet free-sale certificate(National certificate for export or for a foreign authority, under MSS § 32²)45 days45-60 daysVerified
  1. 1Pre-Submission Preparation(1-3 months)
  2. 2Application Submission(1-2 weeks)
  3. 3Administrative Review(2-4 weeks)
  4. 4Technical Evaluation(0 days)
  5. 5Registration Approval(1-2 weeks)

Key regulations

All 3 Estonia regulations →

Official Ravimiamet rules and guidance · 3 of 3 documents linked to official sources

Regulation (EU) 2017/745Medical Devices Regulation (MDR) as it applies in Estonia
RegistrationVerified
RT I, 12.07.2025, 23Meditsiiniseadme seadus (Medical Devices Act)
GeneralVerified
Regulation (EU) 2023/607Transitional provisions for certain medical devices and IVDs, as they apply in Estonia
RegistrationVerified
Continue with this market

Turn Estonia research into practical work

The target market is carried into each tool. Add the product, evidence, or regulatory change you want to assess.

View every AI workpaper →

Build a reusable product master

Structure company, product, model, approval, certificate, and evidence facts before starting Estonia work.

Estonia market-launch workpaper

Connect the Ravimiamet route, evidence, labels, local role, timing, and dependencies to a wider launch plan.

Estonia dossier reuse and delta

Compare an existing authorization and evidence set against Ravimiamet administrative, testing, labeling, and dossier needs.

Estonia change notification workpaper

Map a product or manufacturing change to Ravimiamet evidence, notification, timing, and implementation questions.

Estonia regulatory change impact

Assess a current Ravimiamet update against one product and turn it into an owner-ready action workpaper.

Estonia cybersecurity evidence review

Review connected-device architecture, risks, SBOM, testing, lifecycle controls, and market-specific questions for Estonia (Ravimiamet).

Country hubs in other markets

Other Europe markets

AlbaniaArmeniaAustriaAzerbaijanBelarusBelgiumBosnia and HerzegovinaBulgariaCroatiaCyprusCzech RepublicDenmarkEuropean UnionFinlandFranceGeorgiaGermanyGreeceHungaryIcelandIrelandItalyKazakhstanLatviaLiechtensteinLithuaniaLuxembourgMaltaMoldovaMontenegroNetherlandsNorth MacedoniaNorwayPolandPortugalRomaniaRussiaSerbiaSlovakiaSloveniaSpainSwedenSwitzerlandTurkeyUkraineUnited KingdomAll 114 markets →
DJ Fang
Entering the Estonia market?
Local representation, Ravimiamet submissions, and lifecycle maintenance — handled with an expert.
Pricing